ResearcherMayo ClinicActive in the last 2 years

Haidong Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5782-2983; OpenAlex author ID A5038413156. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

Myeloid–Treg Crosstalk Disruption by Photochemical Activation and Immune Checkpoint Therapy Triples Median Survival in a Pancreatic Cancer Model Last author DOI 10.21203/rs.3.rs-8912367/v1 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tayyaba Hasan · 1 shared paper, 2026 · strength 0.27
- Paper Myeloid–Treg Crosstalk Disruption by Photochemical Activation and Immune Checkpoint Therapy Triples Median Survival in … DOI 10.21203/rs.3.rs-8912367/v1 ↗
Bryan Quilty Spring · 1 shared paper, 2026 · strength 0.27
- Paper Myeloid–Treg Crosstalk Disruption by Photochemical Activation and Immune Checkpoint Therapy Triples Median Survival in … DOI 10.21203/rs.3.rs-8912367/v1 ↗
Mohammad Ahsan Saad · 1 shared paper, 2026 · strength 0.27
- Paper Myeloid–Treg Crosstalk Disruption by Photochemical Activation and Immune Checkpoint Therapy Triples Median Survival in … DOI 10.21203/rs.3.rs-8912367/v1 ↗
Vinay Chandrasekhara · 1 shared paper, 2026 · strength 0.27
- Paper Myeloid–Treg Crosstalk Disruption by Photochemical Activation and Immune Checkpoint Therapy Triples Median Survival in … DOI 10.21203/rs.3.rs-8912367/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.